Pacira BioSciences

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$196,873
$179,516
$181,099
$168,923
Gross Profit
145,238
140,233
134,617
EBITDA
25,805
34,368
29,241
33,609
EBIT
4,463
13,177
1,919
12,441
Net Income
21,317
5,432
-4,847
4,812
Net Change In Cash
196,873
179,516
181,099
168,923
Free Cash Flow
43,471
56,964
9,315
26,911
Cash
158,545
147,589
300,484
283,610
Basic Shares
42,981
44,459
45,459
46,526

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$726,411
$700,966
$674,978
$666,823
Gross Profit
530,538
490,309
467,528
EBITDA
125,343
29,118
154,585
140,379
EBIT
34,320
-49,667
79,011
48,878
Net Income
26,714
-99,560
41,955
15,909
Net Change In Cash
726,411
700,966
674,978
666,823
Free Cash Flow
136,661
178,753
139,488
115,198
Cash
158,545
276,774
153,298
104,139
Basic Shares
45,042
46,245
51,979
46,538

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.57
2025-09-30
$0.70
2025-06-30
-$0.11